DISCLAIMER: This site is for informational purposes only. While we make every effort to keep it up to date, there is no guarantee that information is complete, accurate, comprehensive, or the same for all KP regions. The information on this site should not be interpreted or used as a substitute for professional medical care. Please consult your care provider for any personal health questions or before participating in clinical trials.

Active, currently enrolling

Treatment of opioid use disorder in office settings: the EMBOSS study

NCT No.: NCT06323824

Study Type: INTERVENTIONAL

Phase: Phase IV

Region: Colorado

Acronym: CTN-0131

Official Title

Treatment of opioid use disorder in office settings: the EMBOSS study

Purpose

The research study is comparing methadone versus buprenorphine prescribed in office-based settings for the treatment of opioid use.

Detailed Description

Sex

Male & Female

Age Limit

Eligibility Criteria

Inclusion Criteria

- 18 years of age or older
- Have Opioid Use Disorder
- Seeking treatment for Opioid Use Disorder
- Kaiser Permanente Colorado member

Exclusion Criteria

Additional criteria will be checked by a clinician or study staff at your first visit.

Keywords and/or Specific Medical Conditions

  • Addiction Medicine
  • Psychiatry

Sponsors

  • Yale University

KP Clinical Facility

Clinical Area

  • Addiction Medicine
  • Psychiatry

Principal Investigator

Ingrid A Binswanger , MD 

Contact Information

 - KPCO EMBOSS Team
- 303-739-3666
- EMBOSS@kp.org
- Skyline Medical Offices - Denver

Find a study